Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A new study published in The BMJ has found that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), may face a higher risk of developing non-scarring hair loss (alopecia) compared with patients taking other commonly prescribed diabetes medicines
doi: 10.2337/dc24-S005 10
I love the convenience of doing this at home
If you qualify, be sure to ask how long this program will cover your costs
US$ 23.86
US$ 21.57
US$ 26.43
US$ 28.50
US$ 21.43
US$ 20.09
US$ 21.65
